BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 21586510)

  • 1. Childhood leprosy: lest we forget.
    Sachdeva S; Amin SS; Khan Z; Sharma PK; Bansal S
    Trop Doct; 2011 Jul; 41(3):163-5. PubMed ID: 21586510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood leprosy through the post-leprosy-elimination era: a retrospective analysis of epidemiological and clinical characteristics of disease over eleven years from a tertiary care hospital in North India.
    Dogra S; Narang T; Khullar G; Kumar R; Saikia UN
    Lepr Rev; 2014 Dec; 85(4):296-310. PubMed ID: 25675654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trials of preventive therapy.
    Blanc LJ
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S7-9. PubMed ID: 10700928
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R; Dayal R; Katoch VM; Katoch K
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy at a turning point?
    Harboe M
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in detection of new leprosy cases at two centres in Himachal Pradesh, India: a ten-year study.
    Mahajan VK; Sharma NL; Rana P; Sood N
    Indian J Lepr; 2003; 75(1):17-24. PubMed ID: 15253391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leprosy situation in endemic states of India and prospects of elimination of the disease.
    Subramanian M; Showkath Ali MK; Thorat DM; Muthukumar M; Sathiskumar E; Ramadoss C; Ali Khan M
    Indian J Lepr; 2003; 75(4):335-45. PubMed ID: 15242272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effect of leprosy control in both highly endemic prefectures, Weifang of Shandong and Wenshan of Yunnan].
    Li H; Weng X; Li T
    Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):333-7, 381-2. PubMed ID: 7553142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
    Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLEP--current situation and strategy during the 11th plan period (2007-2012).
    Dhillon GP
    J Indian Med Assoc; 2006 Dec; 104(12):671-2. PubMed ID: 17474280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 14. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR; Gatt P
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic prospects for paucibacillary leprosy.
    Katoch K
    Indian J Lepr; 2000; 72(3):351-61. PubMed ID: 11105276
    [No Abstract]   [Full Text] [Related]  

  • 16. Should large lesions of leprosy be considered as "multibacillary" for treatment purposes even if the total number of lesions is less than five?
    Kumarasinghe SP; Kumarasinghe MP
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):173-4. PubMed ID: 15301583
    [No Abstract]   [Full Text] [Related]  

  • 17. [New WHO recommendations for the treatment of leprosy].
    Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754
    [No Abstract]   [Full Text] [Related]  

  • 18. Multidrug therapy regimen for leprosy.
    Firooz A
    J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233
    [No Abstract]   [Full Text] [Related]  

  • 19. The imperatives of leprosy treatment in the pre- and post-global leprosy elimination era: appraisal of changing the scenario to current status.
    Sehgal VN; Sardana K; Dogra S
    J Dermatolog Treat; 2008; 19(2):82-91. PubMed ID: 17852638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.